Skip to main content
TipRanks
Go Ultimate75% OFF

DV Biomed Co., Ltd. (6539) Financial Statements

DV Biomed Co., Ltd. Financial Overview

DV Biomed Co., Ltd.'s market cap is currently NT$845.25M. The company's EPS TTM is NT$3.16; its P/E ratio is 11.46; and it has a dividend yield of 4.42%. DV Biomed Co., Ltd. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total RevenueNT$ 794.18MNT$ 573.57MNT$ 1.54BNT$ 1.87BNT$ 1.83B
Gross ProfitNT$ 566.63MNT$ 424.50MNT$ 764.28MNT$ 1.04BNT$ 1.02B
Operating IncomeNT$ 14.86MNT$ 108.33MNT$ 148.96MNT$ 386.31MNT$ 416.86M
EBITDANT$ 50.27MNT$ 146.38MNT$ 185.88MNT$ 582.63MNT$ 610.85M
Net IncomeNT$ 7.74MNT$ 89.08MNT$ 162.91MNT$ 281.26MNT$ 304.57M
Balance Sheet
Cash & Short-Term InvestmentsNT$ 327.79MNT$ 380.59MNT$ 277.09MNT$ 585.17MNT$ 600.86M
Total AssetsNT$ 677.18MNT$ 777.22MNT$ 1.81BNT$ 2.05BNT$ 1.86B
Total DebtNT$ 45.51MNT$ 131.74MNT$ 387.70MNT$ 466.52MNT$ 224.09M
Net DebtNT$ -68.45MNT$ -82.24MNT$ 160.70MNT$ 9.70MNT$ -333.53M
Total LiabilitiesNT$ 169.81MNT$ 243.01MNT$ 765.87MNT$ 908.14MNT$ 684.25M
Stockholders' EquityNT$ 507.37MNT$ 534.21MNT$ 1.05BNT$ 1.15BNT$ 1.18B
Cash Flow
Free Cash FlowNT$ 29.64MNT$ 112.82MNT$ 67.09MNT$ 400.36MNT$ 453.28M
Operating Cash FlowNT$ 57.79MNT$ 119.03MNT$ 332.34MNT$ 522.58MNT$ 522.59M
Investing Cash FlowNT$ -86.41MNT$ -30.88MNT$ -178.25MNT$ -198.01MNT$ -104.77M
Financing Cash FlowNT$ -58.21MNT$ -103.30MNT$ -388.14MNT$ -426.01MNT$ -393.86M

Currency in TWD

DV Biomed Co., Ltd. Earnings and Revenue History

0800M1.6B2.4B0 %6 %12 %18 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin

DV Biomed Co., Ltd. Liabilities to Assets

0800M1.6B2.4B24 %32 %40 %48 %LiabilitiesLiabilities to Assets201720182019202020212022202320242025AssetsLiabilitiesLiabilities to Assets

DV Biomed Co., Ltd. Cash Flow

-500M-250M0250M500M750M201720182019202020212022202320242025OperatingInvestingFinancing

DV Biomed Co., Ltd. Forecast EPS vs Actual EPS